HBM Healthcare Investments AG provided earnings guidance for the first nine months ended December 31, 2021. For the period, the company expected a net profit of approximately CHF 275 million for this period (previous year net profit of CHF 644.6 million).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
205 CHF | +0.49% |
|
-1.20% | +12.27% |
28/05 | HBM Healthcare Flags NAV Boost from Yellow Jersey-Johnson & Johnson Deal | MT |
23/05 | HBM Healthcare Investments' Portfolio Company to Buy Laboratorios Biopas Group | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+12.27% | 156.68Cr | |
+22.68% | 327.03Cr | |
+12.50% | 176.45Cr | |
-11.54% | 121.91Cr | |
+31.84% | 87Cr | |
+7.16% | 65Cr | |
+52.03% | 64Cr | |
-4.17% | 50Cr | |
+21.74% | 44Cr | |
+32.76% | 32Cr |
- Stock Market
- Equities
- HBMN Stock
- News HBM Healthcare Investments AG
- HBM Healthcare Investments AG Provides Earnings Guidance for the First Nine Months Ended December 31, 2021